Kristen Mulholland
Known title: EVP, Chief HR OfficerCIK: 0002037288
Associated companies
Transaction History
| JNJ | ▲ Buy | Option Exercise | 419 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 172 | $42K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 575 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 251 | $61K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 410 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 135 | $33K | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 3,602 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 1,027 | $251K | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 5,625 | $573K | 2/6/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 3,335 | $800K | 2/6/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 120 | $19K | 2/18/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 419 | $0 | 2/15/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 141 | $22K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,007 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 290 | $45K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,601 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 457 | $72K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 411 | $0 | 2/13/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Johnson & Johnson: Key Takeaways for Long-Term Investors
Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.
Johnson & Johnson: Key Takeaways for Long-Term Investors. Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.